World Health Organization, Geneva, 22 May 2019
Algeria and Argentina have been officially recognized by WHO as malaria-free. The certification is granted when a country proves that it has interrupted indigenous transmission of the disease for at least 3 consecutive years.
World Health Organization, Geneva, 22 May 2019
The 5th International conference on Malaria Vaccines for the World (MVW) was held on May 8-10 at the University of Oxford, UK. The current status of new technologies, vaccine candidates, clinical trials and the RTS/s implementation studies were discussed during three intensive days, and here you can read coverage of each session from the MESA Correspondents.
- Poor quality anti-malarial drugs causing resistance to develop
- Quality control of drugs essential at all stages before administration
- Health professionals must be trained to detect substandard drugs
Malaria Minute, 10 May 2019
Rory Stewart becomes new Secretary of State for International Development, PMI release their thirteenth Annual Report and the MalaFA report shares the opinion of African experts.
Listen to this podcast
We are a group of four MSc students from the TU Delft in the Netherlands and working on a new mosquito bait to kill mosquitos and reduce the spreading- and infection of malaria. In order to further develop the prorotypes, test them in Kenya and ensure successful implementation, we set up a crowdfunding campaign.
MalaFA (Malaria Futures for Africa) is an opinion research study. It is the first systematic effort in many years to collect expert African views on malaria policy. It was commissioned by Novartis Social Business to capture the thoughts of 68 African malaria experts in 14 sub-Saharan African countries – ministers of health, members of parliament, senior civil servants working in health, heads of national malaria control programmes and representatives of academia and non-governmental organisations (NGOs) working on malaria.
The Compendium of WHO malaria guidance provides, for the first time, a complete list of all formal WHO policy recommendations on malaria in a single resource. The document also serves as a catalogue of all WHO publications on malaria prevention, diagnosis, treatment, surveillance and elimination.
Paris, 25 April 2019 – Today leaders from across the globe meet in Paris to renew commitments and announce new initiatives to accelerate the global movement to end malaria in our lifetime.
“For World Malaria Day, we’re joining countries and partners with a clear message: ‘Zero malaria starts with me,’” says the WHO Director-General, Dr Tedros Adhanom Ghebreyesus, in his World Malaria Day message. “We’re calling on political leaders, the private sector and affected communities to take action to improve prevention, diagnosis and treatment of malaria. We all have a role to play.”
Country first of three in Africa to roll out landmark vaccine
WHO welcomes the Government of Malawi’s launch of the world’s first malaria vaccine today in a landmark pilot programme. The country is the first of three in Africa in which the vaccine, known as RTS,S, will be made available to children up to 2 years of age; Ghana and Kenya will introduce the vaccine in the coming weeks.
Nature News, 16 April 2019
A malaria vaccine that can provide up to 100% protection against the disease will be tested in a large clinical trial for the first time, to study its efficacy under real-world conditions.
Senior Biostatistician Malaria Project
ISGloblal has a vacancy for an experienced Biostatistician to join the BOHEMIA project in Barcelona, Spain. Deadline for applications: May, 3rd 2019. Read more
This weeks Malaria Minute Podcast
Australian Veteran Calls for Royal Commission into Tafenoquine
Combining data on parasite genetics and human movement provides greater insight into how malaria spreads, Nigeria loses N132 billion to malaria each year and Stuart McCarthy, an Australian veteran, calls for a Royal Commission into Tafenoquine. Listen to "Australian Veteran Calls for Royal Commission into Tafenoquine"
Global Malaria News
CDC: Artesunate Now First-Line Treatment for Severe Malaria in the United States
CDC, 28 March 2019
CDC is issuing new guidance to clinicians for the treatment of severe malaria cases in the United States (U.S.). This change in treatment protocol is necessary because the only FDA-approved intravenous (IV) antimalarial drug in the U.S., quinidine, has been discontinued by the manufacturer and will no longer be available. Read this article
New model predicts substantial reduction of malaria transmitting mosquitoes
Phys.org, 28 March 2019
In new research published today in BMC Biology a team of scientists model the potential of modifying mosquitoes with a gene-drive technology called "driving-Y chromosome". Dr. Abdoulaye Diabate from the Institut de Recherche en Science de la Santé (IRSS), Burkina Faso, said: 'There is evidence that this approach, with the right national and international approvals, could be rolled out within the next 10 years.' Read this article
Enjoy this week's MalariaWorld - the MW team
If you are working on malaria in East or Southern Africa you are invited to participate in the survey of the Embassy of Switzerland to Tanzania and Zambia.*
Cyclone Idai Causes ‘Spike’ in Malaria Cases
By Thomas Locke
Cyclone Idai causes ‘spike’ in malaria cases, Oxford Uni researchers head to Africa to sequence mosquito DNA and the NothingButNets Leader Summit takes place in the US capitol.
Listen to this podcast
The University of Malaya hosted the "Current Tools to Combat Malaria - with Special Focus on Plasmodium knowlesi" workshop on March 4 - 8, 2019, which had 20 participants from eight different countries. Dr Lucas Low Van Lun covered this intensive week of lectures and practical sessions and reported the daily lessons learnt in a series of reports posted in the Resource Hub.
The Guidelines for malaria vector control provide a “one-stop shop” for all countries and partners working to implement effective malaria vector control measures. They cover the 2 core malaria vector control interventions – ITNs and IRS – as well as supplementary interventions, namely chemical and biological larvicides, and personal protection measures, such as the use of topical repellents.
Geneva – Paris, 25 February 2019 Today the RBM Partnership to End Malaria announced that Paris, France, will be the official host city of World Malaria Day 2019 on 25th April.
This report has been prepared to provide a comprehensive account of the history of malaria and its control in the Islamic Republic of Iran for specialists and lay readers alike. It is based on published and unpublished reports, especially from the Ministry of Health and Medical Education, Tehran, and from the World Health Organization. The main findings are summarized below.
WHO is undertaking a consultative process to solicit inputs into a prioritization framework for the research and development (R&D) of malaria health products. A draft report “Analysis of Malaria R&D Priorities” identifies five key challenges that represent threats or barriers to achieving the WHO Global Technical Strategy for Malaria 2016–2030 goals. This early copy of the report is being shared at a time when WHO is exploring how best to guide and support the development of priority solutions to meet public health needs.
WHO welcomes feedback on this draft report until 28 February 2019, including the correction of errors or omissions, updates to product development pipelines, and perspectives on the approach to prioritization.
FRANCE 24 brings you an in-depth investigation into the debate between those for and against this natural anti-malaria remedy, which appears as a threat to large pharmaceutical laboratories.
MESA co-hosting a critical global gathering in response to the latest disease reality and future innovation and financing needs
The MESA Alliance is set to co-host an invite-only scientific symposium entitled, “Innovate for Collective Impact to End Malaria”, on Friday, January 11, 2019, at the National Academy of Sciences in Washington, DC, USA. Its core objective is to frame a response to the 2018 World Malaria Report and to develop innovative approaches to collectively bridge critical issues in malaria eradication spanning research, financing, and implementation.
We are proud to inform you that MalariaWorld's Bart Knols has won the Marc Cornelissen Brightlands Award 2018 for his work in the fight against malaria.
Malaria is on the rise in more than 13 countries. And that is very scary!
This year's report shows that after an unprecedented period of success in global malaria control, progress has stalled. Data from 2015–2017 highlight that no significant progress in reducing global malaria cases was made in this period. There were an estimated 219 million cases and 435 000 related deaths in 2017.
The World malaria report 2018 draws on data from 91 countries and areas with ongoing malaria transmission. The information is supplemented by data from national household surveys and databases held by other organizations.
The most promising or the most frightening experiment in the fight against malaria: should or shouldn’t we use genetically modified mosquitoes to combat malaria?
TEXAS BIOMEDICAL RESEARCH INSTITUTE - PUBLIC RELEASE: 17-OCT-2018
More than 150 people have died from Ebola virus disease in 2018
San Antonio, Texas (October 17, 2018) -- Ebola virus is a continuing threat in Central and West Africa, with an outbreak currently taking place in the Democratic Republic of Congo. The disease kills up to 90% of the people who get infected, and more than 150 people have died from Ebola so far this year. The factors that determine who is susceptible to Ebola infection and who is not are still a mystery.